Published 4 days ago • loading... • Updated 3 days agoShow Less IconNovo hikes guidance on Wegovy pill’s fast sales start Summary by PharmaVOICESales and profit should shrink less than originally anticipated thanks to strong momentum for its new obesity pill, the drugmaker said in its most recent earnings report.Share menu2 Articles2 ArticlesAllLeftCenter1RightSearch IconSort IconPharmaVOICECenterFactualityOwnershipNovo hikes guidance on Wegovy pill’s fast sales startSales and profit should shrink less than originally anticipated thanks to strong momentum for its new obesity pill, the drugmaker said in its most recent earnings report.4 days agoRead Full Articlepharmaceutical-technology.comFactualityOwnershipNovo’s CEO champions “record-breaking start” for Wegovy pill in US market - Pharmaceutical TechnologyNovo Nordisk’s Wegovy pill is already providing financial fuel in the company’s bid to catch Eli Lilly.3 days agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources2Leaning Left0Leaning Right0Center1Last Updated3 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Untracked biasFactuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantagePharmaVOICE broke the news 4 days ago on Thursday, May 7, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsWegovy Plus IconUnited States Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsWegovy Plus IconUnited States Plus IconShow All